Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Annals of the Rheumatic Diseases

Ab0623 Impact of Tofacitinib on Lipid Metabolism in Patients With Rheumatoid Arthritis: A Real-World Study

View Full Paper
Ask AI
Bookmark
Share

Authors

HHHong HuangYGYan GengZZZ. Zhang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huang et al. (2024) studied this question.

synapsesocial.com/papers/68e671b5b6db6435875fbc1ahttps://doi.org/10.1136/annrheumdis-2024-eular.5600
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trajectory of lipid profiles in rheumatoid arthritis patients receiving tofacitinib: Evidence from the prospective CENTRA cohort2026
  2. 2AB0653 IMPACT OF TSDMARD, TOFACITINIB, ON ENDOTHELIAL FUNCTION IN RA AND ITS ASSOCIATION WITH CELLULAR RATIOS2024
  3. 3Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)2026
  4. 4Real‐World Data of Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Taiwanese Patients With Rheumatoid Arthritis From a Drug‐Based Cohort Study2026
  5. 5Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients2024 · 10 citations